J4

• 临床研究 • 上一篇    下一篇

急性冠脉综合征患者CD61、CD62p的表达和血浆vWF含量的变化及药物干预作用

周雪艳1,杨 萍1,郑德明1,袁志宏1,周传开1,郭 君1*   

  1. 1. 吉林大学中日联谊医院心内科,吉林 长春130033;2. 卫生部长春生物制品研究所,吉林 长春130062
  • 收稿日期:2005-04-27 修回日期:1900-01-01 出版日期:2006-09-28 发布日期:2006-09-28
  • 通讯作者: 郭 君

Changes of expressions of CD61p, CD62p and plasma vWF concentration in patients with acute coronary syndrome and drug intervention

ZHOU Xue-yan1, YANG Ping1, ZHENG De-ming, YUAN Zhi-hong2, ZHOU Chuan-kai2,GUO Jun1*   

  1. 1.Department of Cardiology, China-Japan Union Hospital, Jilin University, Changchun 130033,China;2.Changchun Institute of Biological Products,Changchun 130062,China
  • Received:2005-04-27 Revised:1900-01-01 Online:2006-09-28 Published:2006-09-28
  • Contact: GUO Jun

摘要: 目的:探讨急性冠脉综合征(ACS)血小板颗粒膜糖蛋白(CD62p)及血小板脂膜蛋白(CD61)与血浆假性血友病因子(vWF)的关系及奥扎格雷的干预作用。方法:应用流式细胞术(FCM)和酶联免疫吸附试验(ELISA)测定36例ACS患者硝酸酯+奥扎格雷钠治疗前后静脉血CD62p、CD61和血浆vWF的表达水平,对两者在ACS时的变化进行对比分析。同时设20例健康体检者做对照组。结果:ACS患者CD62p是[(89.60±6.98)%],表达明显高于正常组[(40.88±7.56)%](P<0.05),药物干预治疗后下降至(66.11±8.72)%,治疗前后比较差异亦具有显著性(P<0.05),其水平变化与vWF、心绞痛和缺血ST-T改善一致;CD61表达量为(91.38±6.97)%,与正常组比较差异无显著性(P>0.05),药物干预治疗前后比较,差异无显著差性(P>0.05)。结论:CD62p是血小板活化的敏感指标,且与vWF和临床症状有很好的相关性。

关键词: 血小板膜糖蛋白类, von Willebrand, 急性病, 综合征

Abstract: Objective To study the effects of Ozagre on CD62p,CD61, which was used as platelet marks and von willebran factor (vWF) in patients with acute coronary syndrome (ACS),and meanwhile to study the relationships between CD62p,CD61 and vWF. Methods CD62p ,CD61 from whole-blood samples were measured by FCM and vWF was measured by ELISA method in 36 patients with ACS and 20 normal peoples used as control group. Results The amount of expression of CD62p was(89.60±6.98)% in ACS patients group and (40.88±7.56)% in control group, there was obvious difference between ACS group and control group (P<0.05). The amount of CD62p was decreased to (66.11±8.72)% after treated with Ozagre (P<0.05). There was also significant difference of CD62p in ACS group between before and after intervention of ozagre (P<0.05). The amount change of CD62p in patients with ACS was agreement with the improvement of angina pectoris and the changes in sum of ST segements. However there was no difference of CD61 between ACS group and control group (P>0.05).There was also no difference of CD61 between before and after treatment of Ozagre(P>0.05). Conclusion CD62p is a sensitive index of platelet activation in ACS patients and there is excellent relationship between CD62p and vWF and clinical symptoms.

Key words: platelet membrane glycoproteins, von Willebran factor, acute disease, syndrome

中图分类号: 

  • R541.4